Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Am J Physiol Heart Circ Physiol ; 301(3): H964-74, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21724863

RESUMEN

Hypertension is associated with the development of atrial fibrillation; however, the electrophysiological consequences of this condition remain poorly understood. ATP-sensitive K(+) (K(ATP)) channels, which contribute to ventricular arrhythmias, are also expressed in the atria. We hypothesized that salt-induced elevated blood pressure (BP) leads to atrial K(ATP) channel activation and increased arrhythmia inducibility. Elevated BP was induced in mice with a high-salt diet (HS) for 4 wk. High-resolution optical mapping was used to measure atrial arrhythmia inducibility, effective refractory period (ERP), and action potential duration at 90% repolarization (APD(90)). Excised patch clamping was performed to quantify K(ATP) channel properties and density. K(ATP) channel protein expression was also evaluated. Atrial arrhythmia inducibility was 22% higher in HS hearts compared with control hearts. ERP and APD(90) were significantly shorter in the right atrial appendage and left atrial appendage of HS hearts compared with control hearts. Perfusion with 1 µM glibenclamide or 300 µM tolbutamide significantly decreased arrhythmia inducibility and prolonged APD(90) in HS hearts compared with untreated HS hearts. K(ATP) channel density was 156% higher in myocytes isolated from HS animals compared with control animals. Sulfonylurea receptor 1 protein expression was increased in the left atrial appendage and right atrial appendage of HS animals (415% and 372% of NS animals, respectively). In conclusion, K(ATP) channel activation provides a mechanistic link between salt-induced elevated BP and increased atrial arrhythmia inducibility. The findings of this study have important implications for the treatment and prevention of atrial arrhythmias in the setting of hypertensive heart disease and may lead to new therapeutic approaches.


Asunto(s)
Fibrilación Atrial/metabolismo , Función Atrial , Presión Sanguínea , Hipertensión/metabolismo , Canales KATP/metabolismo , Miocitos Cardíacos/metabolismo , Potasio/metabolismo , Cloruro de Sodio Dietético , Transportadoras de Casetes de Unión a ATP/metabolismo , Potenciales de Acción , Análisis de Varianza , Animales , Antiarrítmicos/farmacología , Fibrilación Atrial/etiología , Fibrilación Atrial/patología , Fibrilación Atrial/fisiopatología , Fibrilación Atrial/prevención & control , Función Atrial/efectos de los fármacos , Modelos Animales de Enfermedad , Electrocardiografía , Fibrosis , Atrios Cardíacos/metabolismo , Atrios Cardíacos/fisiopatología , Hipertensión/tratamiento farmacológico , Hipertensión/etiología , Hipertensión/patología , Hipertensión/fisiopatología , Canales KATP/antagonistas & inhibidores , Masculino , Ratones , Miocitos Cardíacos/efectos de los fármacos , Miocitos Cardíacos/patología , Técnicas de Placa-Clamp , Bloqueadores de los Canales de Potasio/farmacología , Canales de Potasio de Rectificación Interna/metabolismo , Receptores de Droga/metabolismo , Periodo Refractario Electrofisiológico , Sarcolema/metabolismo , Receptores de Sulfonilureas , Factores de Tiempo , Imagen de Colorante Sensible al Voltaje
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...